Eye On OOSS: The Proposed 2026 ASC Rule Disappoints

The Proposed 2026 ASC Rule Disappoints

By: Diane Blanck, Michael A. Romansky, JD

Ophthalmology Management October 1, 2025 Page(s): 17, BC

Clinical Report: The Proposed 2026 ASC Rule Disappoints

Overview

The proposed 2026 ASC rule fails to account for rising operational costs in ASCs, particularly in cataract surgery. The reduction in facility fees threatens the quality of care and may drive services back to more expensive hospital settings.

Background

The financial viability of ambulatory surgical centers (ASCs) is critical for maintaining access to high-quality ophthalmic care. Recent trends indicate significant increases in operational costs, yet proposed reimbursement adjustments do not reflect these realities. This disconnect could jeopardize the ability of ASCs to provide essential services to Medicare patients.

Data Highlights

No numerical data provided in the source material.

Key Findings

The proposed cost-of-living update does not align with actual increases in ASC operational expenses.
ASCs receive approximately 50% of the reimbursement that hospital outpatient departments receive for similar services.
Reductions in facility fees for cataract surgery could compromise the quality of care provided to patients.
OOSS is actively coordinating with multiple organizations to contest the proposed CMS payment reductions.
Upcoming educational events aim to address operational challenges and enhance ASC financial performance.

Clinical Implications

Healthcare professionals should be aware of the potential impact of reimbursement changes on the quality of care in ASCs. Advocacy efforts are essential to ensure that ASCs receive adequate support to maintain high standards of patient care.

Conclusion

The proposed 2026 ASC rule presents significant challenges for ophthalmic ASCs, necessitating concerted advocacy efforts to protect the quality of care for Medicare patients.

PentaVision

Ophthalmology Management